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The gut microbiota of a healthy person may not be equivalent to a healthy microbiota. It is possible that the
Western microbiota is actually dysbiotic and predisposes individuals to a variety of diseases. The asym-
metric plasticity between the relatively stable human genome and the more malleable gut microbiome sug-
gests that incompatibilities between the two could rapidly arise. The Western lifestyle, which includes a diet
low in microbiota-accessible carbohydrates (MACs), has selected for a microbiota with altered membership
and functionality compared to those of groups living traditional lifestyles. Interactions between resident
microbes and host leading to immune dysregulation may explain several diseases that share inflammation
as a common basis. The low-MAC Western diet results in poor production of gut microbiota-generated
short-chain fatty acids (SCFAs), which attenuate inflammation through a variety of mechanisms in mouse
models. Studies focused on modern and traditional societies, combined with animal models, are needed
to characterize the connection between diet, microbiota composition, and function. Differentiating between
an optimal microbiota, one that increases disease risk, and one that is causative or potentiates disease will
be required to further understand both the etiology and possible treatments for health problems related to
microbiota dysbiosis.The GutMicrobiota: A Control Center for Human Biology
The human gut harbors a diverse ecosystem of trillions of micro-
bial cells (Costello et al., 2012; Qin et al., 2010). The traditional
view that gut microbiota effects are limited to the host’s digestive
tract, or more recently extended to metabolism and immune sta-
tus, has given way to the realization that these microbes can
have widespread impact on diverse aspects of a host’s physi-
ology (Sommer and Backhed, 2013). Externally applied forces,
such as diet or antibiotics, result in rapid alterations of the micro-
biota, thereby affecting the status of host-microbiota relations
(David et al., 2014; Dethlefsen et al., 2008; Dethlefsen and Rel-
man, 2010; Walker et al., 2011). The malleability of our gut resi-
dents is further reframing this community’s role as a platform
for rational manipulation of host biology: the microbiota provides
a manipulatable lever to improve human health and to treat or
prevent disease (Sonnenburg and Fischbach, 2011; van Nood
et al., 2013; Vrieze et al., 2012).
At a more fundamental level, the very plasticity that makes the
gut microbiota an attractive therapeutic avenue can result in un-
intentional and maladaptive changes, or dysbiosis. A plethora of
microbiota enumeration studies in recent years have implicated
microbiota dysbiosis in a growing list of Western diseases, such
as metabolic syndrome, inflammatory bowel disease, and can-
cer. These studies rely on comparing the microbiota of individ-
uals that are diseased to those that are healthy. The contribution
of the dysbiotic microbiota to disease phenotype has been illus-
trated via microbiota transplant in several instances (Koren et al.,
2012; Liou et al., 2012; Ridaura et al., 2013; Turnbaugh et al.,
2006; Vijay-Kumar et al., 2010). However, use of the term
‘‘dysbiotic’’ must be accompanied by the recognition that thedefinition of a healthy microbiota that should serve as a frame
of reference is still poorly defined. It is possible that the micro-
biota of a healthy Westerner is also dysbiotic, significantly
increasing the risk of developing diseases characterized by
excessive or inappropriate immune inflammatory responses.
Microbiota-Accessible Carbohydrates: Food for
the Masses
Much of the carbon and energy for members of the microbiota
originate from plant- and animal-derived dietary carbohydrates
(Koropatkin et al., 2012; Salyers et al., 1977). These carbohy-
drates are composed of monosaccharides that are connected
through numerous types of glycosidic linkages and, in some
instances, further modified by chemical substituents like acetyl
and sulfate groups. The variation in their chemical composition,
solubility, and size differentiates these carbohydrates into a vast
array of ecological niches. However, microbial competition
within the gut is intense for metabolic access to the energy
and carbon sequestered in these molecules. Residents of the
microbiota are equipped with a specialized collection of en-
zymes such as glycoside hydrolases and polysaccharide lyases,
which can break down complex carbohydrate linkages into
consumable oligosaccharides or monosaccharides (Cantarel
et al., 2009; Martens et al., 2011). A model microbiota containing
160 species has in excess of 9,000 glycoside hydrolases and
2,000 polysaccharide lyases, which serve as the gateway to a
complex microbial food web within the gut (El Kaoutari et al.,
2013). When extrapolating to 1,000 species, a single human
gut microbiota may contain upward of 60,000 carbohydrate-de-
grading enzymes. The human genome, on the other hand, hasCell Metabolism 20, November 4, 2014 ª2014 Elsevier Inc. 779
Box 1. Microbiota-Accessible Carbohydrates
MACs are carbohydrates that are metabolically available to gut microbes. MACs include carbohydrates that are dietary and resis-
tant to degradation and absorption by the host, and they may be secreted by the host in the intestine (e.g., mucus) or produced by
microbes within the intestine. Dietary MACs may come from a variety of sources including plants, animal tissue, or food-borne
microbes, but must bemetabolized by themicrobiota. Much of the cellulose humans consume is not metabolized by gut microbes
and does not qualify as a MAC (Chassard et al., 2010). The amount of dietary MACs present in a single food source differs for
each individual, since which carbohydrates are metabolized depends upon the membership of each person’s microbiota. The
individuality of which carbohydrates qualify as MACs is illustrated by the presence of genes for the consumption of the algal
polysaccharide porphyran in the microbiomes of Japanese individuals, rarely found in North American and European individuals
(Hehemann et al., 2010, 2012). For those harboring a porphyran-degrading strain, porphyran would be a MAC; but for those
without a microbiota adaptation to seaweed, porphyran would not be a MAC. Similarly, germ-free mice that lack a microbiota
might consume a diet high in potential MACs, but none of the carbohydrates would be considered bona fide MACs, since they
would transit the digestive tract unmetabolized by microbes. Alternatively, lack of dietary MACs results in a microbial community
reliant upon endogenous host-derived MACs in the form of mucin glycans (Sonnenburg et al., 2005). Different host genotypes can
influence the identity of MACs available to the microbiota in multiple ways. For example, host genotype can dictate alteration of
mucus structures, such as the absence of alpha-1-2 fucose residues in the mucus of nonsecretor individuals that lack alpha-1-2-
fucosyltransferase activity in the intestine (Kashyap et al., 2013b). Similarly, host genotype can determine how efficiently carbo-
hydrates are digested and absorbed in the small intestine. For example, lactose becomes a substrate for the microbiota in people
who are lactose intolerant, and therefore should be considered a MAC for these individuals. For nursing infants, dietary MACs in
breast milk are known as humanmilk oligosaccharides (Bode, 2012; Marcobal et al., 2010, 2011). Therefore, the term ‘‘microbiota-
accessible carbohydrate’’ contributes to a conceptual framework for investigating and discussing the amount of metabolic activity
that a specific food or carbohydrate can be expected to produce within a given microbiota (Figure 1).
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saccharide lyases that are involved in carbohydrate digestion
within the gut.
Carbohydrates for gut microbe fermentation can come from a
variety of sources including (1) dietary or host-derived animal gly-
cans (2) synthesized by other microbes that are food-borne (e.g.,
the yeast cell wall) or a gut resident, and (3) dietary plant material,
commonly referred to as dietary fiber, which is themost common
fuel for the microbiota of many humans (Flint et al., 2012; Koro-
patkin et al., 2012). The role of dietary fiber on human health
has been discussed for decades. In the 1960s and 1970s, Denis
Burkitt and Hugh Trowell documented the significantly larger
intake of dietary fiber by Africans relative to Westerners and their
coincident lack of Western diseases such as diabetes, heart dis-
ease, and colorectal cancer. Many of these diseases, including
asthma, allergies, and inflammatory bowel diseases, appear in
young Westerners and are therefore not simply a product of our
modern extension of lifespan, but share a dysregulated immune
system as a common basis. Burkitt reported that rural Africans
passed stool that was up to five times greater bymass, had intes-
tinal transit times that were more than twice as fast, and ate
three to seven times more dietary fiber (60–140 g versus 20 g)
than their Western counterparts (Burkitt et al., 1972). However,
the mechanisms by which dietary fiber would exert positive
health effects were unknown. Burkitt and others hypothesized
that the increased transit time and stool size that accompanied
a high-fiber diet may serve to dilute potentially hazardous
microbial metabolic products and quickly remove them from
the colonic lining (Burkitt and Trowell, 1977; Trowell and Burkitt,
1986). But recent studies are suggesting that the missing mech-
anistic explanation for the beneficial effects of dietary fiber may
be largely attributed to fermentation by the microbiota.
In discussing carbohydrate substrates that fuel the colonic mi-
crobial ecosystem, dietary fiber is a problematic term commonly780 Cell Metabolism 20, November 4, 2014 ª2014 Elsevier Inc.employed for lack of a better option. The definition of dietary fiber
has evolved over the past 60 years since the concept was first
introduced (Hipsley, 1953; Trowell, 1976; Trowell et al., 1976;
Trowell and Burkitt, 1987). Current use of this term is compli-
cated by multiple definitions associated with different official
organizations (Raninen et al., 2011). In addition, multiple labora-
tory tests may be used to determine ‘‘dietary fiber’’ content
specified on nutritional labels, none of which provides an accu-
rate measure of what the definitions specify. The most standard
method of quantifying dietary fiber content neglects many types
of carbohydrates that are destined for microbiota fermentation in
the colon, like inulin, but includes noncarbohydrate entities like
lignin. In addition, the term dietary fiber encompasses the carbo-
hydrates that are fermentable by an individual’s microbiota
plus those that remain unfermented and serve a bulking role (Ka-
shyap et al., 2013a). Attempts to use measurements of soluble
verses insoluble fiber as approximations of fermentable versus
nonfermentable, respectively, have proven inaccurate. Similar
to ‘‘dietary fiber,’’ the term ‘‘plant polysaccharides’’ is a common
euphemism for ‘‘microbiota food,’’ but this category excludes
important nonplant carbohydrates and oligosaccharides.
When referring to the carbohydrates that can be metabolically
used by gut microbes, we propose the term ‘‘microbiota-acces-
sible carbohydrate’’ (MAC; see Box 1 for expanded discussion of
MACs). MACs serve as selective agents, altering the composi-
tion of the microbiota, but also dictate the functionality and
metabolic output. Multiple studies have shown that diet can
serve as a selective potent force in reshaping themicrobiota (Da-
vid et al., 2014; Walker et al., 2011; Wu et al., 2011). Highly
controlled experiments in mice have shown that the quantity
and type of carbohydrates that feed the microbiota alter simpli-
fied and complex microbial communities (Faith et al., 2011; Ka-
shyap et al., 2013a; Sonnenburg et al., 2010; Turnbaugh et al.,
2009b). Humans eating controlled diets supplemented with
Figure 1. The Divergent Metabolic
Scenarios of a High-MAC versus a
Low-MAC Diet
Two scenarios represent a trade-off in how calo-
ries are absorbed by the host. In the first scenario,
a high-MAC diet that has few simple sugars, the
major contribution of carbohydrates to host
metabolism is in the form of the SCFA fermenta-
tion end-products of the microbiota. In addition to
calories, these molecules play diverse regulatory
roles in human physiology, including protection
from many Western diseases. In the second sce-
nario, the low-MAC Western diet results not only
in a loss of beneficial microbial metabolites such
as SCFA, but also in selection of a distinct mi-
crobiota that may seem foreign to the host.
Increased representation of mucus-utilizing mi-
crobes, decreased gut motility, and increased
calories in the form of sugar and fat may synergize
to cause Western diseases. MACs include car-
bohydrates from diet, host secretion (e.g., mucin
glycans), or other resident microbes that serve as
a metabolic input for members of the microbiota.
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levels of potential MACs, exhibit diet-induced alterations in mi-
crobiota composition (Walker et al., 2011). Due to the ‘‘gateway’’
role of primary fermenters within the colonic ecosystem, MACs
can promote certain microbes either directly (those that
consume a substrate) or indirectly (via crossfeeding interactions)
(Fischbach and Sonnenburg, 2011). Despite a large gap in our
understanding of how the diversity and quantity of dietary
MACs influence host health, many studies are strengthening
the links between MACs, microbiota diversity and metabolism,
and host health.
MACs and Microbiota Diversity
Accumulating data suggest that host health is linked to dietary
MAC-induced alterations in microbiota composition and diver-
sity. A dietary intervention performed on 49 obese individuals
showed an increase in microbiota gene richness when partici-
pants reduced energy intake and increased dietary fiber con-
sumption for 6 weeks (Cotillard et al., 2013). In mice, reduction
of dietary fiber has a direct effect on microbiota diversity and
short-chain fatty acid production; the latter is an indication that
indeed the dietary fiber includes MACs (Kashyap et al., 2013b;
Trompette et al., 2014). Recently, a significant and reversible
difference in microbiota composition was observed in humans
that shifted to either a diet of all plants or one of all animal prod-
ucts, illustrating the impact diet has on microbiota composition
(David et al., 2014). However, despite significant increases in di-
etary fiber (and presumably MAC) intake over the 4-day plant-
based diet, an increase inmicrobiota diversity was not observed.
Four days of increased dietary MACs may be an insufficient time
period to for previously rare (undetectable) species to flourish or
for environmentally acquired microbes to entrench. It remains to
be determined whether the simplified Western microbiota has
lost species that cannot be recovered upon increased dietary
MACs.Additional human studies have correlated increased dietary
MAC consumption to microbiota composition, diversity, and
health. The gut microbiota of children from a rural village in Bur-
kina Faso revealed stark differences compared to a ‘‘healthy’’
Western cohort in Italy (De Filippo et al., 2010). In addition to
disparity in represented phylotypes, relative to the Europeans,
the African group showed (1) an altered ratio of the two dominant
phyla of the human microbiota, with increased representation of
Bacteroidetes relative to Firmicutes (the opposite of the Bacter-
oidetes depletion associated with obesity in several studies) (Ley
et al., 2005, 2006; Turnbaugh et al., 2009a); (2) increased micro-
biota diversity; and (3) large increases of SCFA production
including 4-fold more butyrate and propionate. These changes
coincide with nearly twice the dietary fiber intake in the African
group compared to the European group.
Our Ancient Microbiota
While the Burkina Faso study strengthened the link between diet
andmicrobiota diversity, it also provided the first glimpse at what
the human microbiota may have looked like during the Neolithic
revolution in agriculture as humans embraced cultivated foods.
An independent study of rural groups in Malawi and Venezuela
similarly revealed greater bacterial diversity and stark differ-
ences inmicrobiota composition of nonmodern societies relative
to Western groups (Figure 2). The microbiota from all three tradi-
tional agrarian groups in Malawi, Venezuela, and Burkina Faso
were more similar to one another in microbiota diversity and
SCFA production than to their Western counterparts (Yatsu-
nenko et al., 2012). In addition to supporting the view that the
modern microbiota deviates substantially from ancestral states,
these findings point to the need to infer the microbiota at addi-
tional time points of human evolution, such as that of preagricul-
tural humans.
Hunting and gathering was the lifestyle that dominated for the
longest time span in our species existence. The Hadza, a groupCell Metabolism 20, November 4, 2014 ª2014 Elsevier Inc. 781
Figure 2. The Western Microbiota Diverges from That of
Non-Western Populations
(A) Principle coordinate plot of gut microbiota composition in individuals (each
dot represents one person’s microbiota) from three populations based on
Unifrac distances of the bacterial 16S rRNA profile. Distance between dots
represents extent of compositional difference.
(B) Average number of bacterial phylotypes detected within the gut microbiota
from three populations; error bars indicate SEM. Data reprinted with permis-
sion (Yatsunenko et al., 2012).
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erers in Africa and represent one of the best modern approxima-
tions of preagricultural humans (Marlowe, 2010). A recent study
comparing the microbiota of 27 Hadza to 16 Italians, who repre-
sent a Western cohort, showed many interesting differences,
including a relative enrichment of the Prevotella genus, the pres-
ence of Treponema species, and the lack of Bifidobacterium
(Schnorr et al., 2014). Perhaps their most significant finding is
themuch larger extent of bacterial diversity in the foragingmicro-
biota compared to the industrialized group.
Interpretation of these studies comes with important caveats.
Most studies focus on the bacterial component of the gut
microbiota, excluding important archaea, eukaryotes, and
viruses. All of these rural populations are composed of modern
people that approximate, but are not exact representations of,
a human ancestral state. Furthermore, it is almost certain that
there was no single ‘‘ancestral state’’ for any given time in hu-
man evolution. As humans radiated across the planet, diverse
lifestyles, diets, locations, and genetic differences likely re-
sulted in microbiota variation within populations; it is certain
that even gradients of transculturation exist within each indige-
nous cohort. So additional microbiota data, coupled with meta-
data about diet and lifestyle from these and other traditional
populations, will be required to place these initial findings into
context. Paleogenomics offer an alternative avenue to eluci-
date, rather than infer, microbiotas of the past (Tito et al.,
2012). The major dietary shifts occurring between the hunter-
gatherer lifestyle, early Neolithic farming, and more recently
during the Industrial Revolution are reflected in changes in mi-
crobial membership within dental tartar of European skeletons
throughout these periods (Adler et al., 2013). Notably, the tran-
sition to our modern lifestyle has been accompanied by the782 Cell Metabolism 20, November 4, 2014 ª2014 Elsevier Inc.appearance of cariogenic bacteria and markedly reduced oral
microbiota diversity.
Microbiota Metabolism and Host Health
Two independent studies of individuals in Europe have illustrated
that microbiome diversity is linked to human health (Cotillard
et al., 2013; Le Chatelier et al., 2013). The 341 combined partic-
ipants from both studies were comprised of obese, overweight,
and healthy individuals and exhibited a bimodal distribution of
microbiota gene content: some individuals exhibited low gene
count (LGC) and others high gene count (HGC). The LGC group
was more insulin resistant and had higher fasting triglycerides,
higher LDL cholesterol, and higher markers of inflammation rela-
tive to the HGC group. Dietary intervention of 49 obese or over-
weight individuals (18 from the LGC group and 27 from the HGC
group) resulted in loss of fat mass and was accompanied by im-
provements in clinical markers such as lipid and insulin values,
insulin resistance, and measures of inflammation for both the
LGC and HGC groups (Cotillard et al., 2013). However, improve-
ments in these clinical markers were most pronounced for the
HGC group, indicating that microbiome richness was a predictor
of response to diet-induced improvements. Dietary intervention
did result in an increase in gene richness in the LGC cohort that
approached but still remained significantly lower than the HGC.
Together these independent studies indicate that metabolic dis-
ease clinical phenotypes are associated with gene content diver-
sity of the gut microbiota and that diet can directly impact this
diversity.
The mechanisms underlying the link between microbiota di-
versity and health are still unknown, but SCFAs appear to be
one likely mediator. It is possible that microbiota diversity is
an intermediate correlate of high-MAC diets and that fermenta-
tion end-products absorbed into circulation are important effec-
tors of host physiology. The short-chain fatty acids, acetate,
propionate, and butyrate, are common end-products of carbo-
hydrate-fermenting microbes in the distal gut (Wong et al.,
2006), and several factors, including dietary substrates, can
affect the relative ratios and concentrations (Macfarlane and
Macfarlane, 2003; Topping and Clifton, 2001). SCFAs are
absorbed by the host and serve as calories salvaged from
otherwise inaccessible carbohydrates, but they also play
diverse regulatory roles including regulating histone acetylation
and signaling through G protein coupled receptors (Bergman,
1990; Brown et al., 2003; Davie, 2003). Recently several groups
have linked microbiota-generated SCFAs to anti-inflammatory
effects. SCFAs increase the pool of regulatory T cells in the
gut, and MAC-dependent SCFAs produced by the gut micro-
biota are protective of allergic airway inflammation in a mouse
model (Arpaia et al., 2013; Furusawa et al., 2013; Smith et al.,
2013; Trompette et al., 2014). Multiple studies indicate a depen-
dence upon fatty-acid, G protein-coupled receptors (GPR41 or
GPR43).
SCFAs regulate energy homeostasis, a role to which the bene-
ficial metabolic effects of fiber have been attributed (Layden
et al., 2013). Butyrate appears to broadly influence metabolism
and circulating propionate signals via the afferent nervous sys-
tem to influence gluconeogenesis in the intestine, as well as
results in improved metabolic profiles and reduced weight gain
(De Vadder et al., 2014; Gao et al., 2009; Lin et al., 2012).
Figure 3. The Multiple-Hit Hypothesis for
How the Microbiota of Industrialized
Societies Has Lost Diversity over Time
(A) Microbiota diversity was likely altered at mul-
tiple stages of human evolution. As diversity and
quantity of dietary MACs decreased with agricul-
ture, industrialized food production, and pro-
cessed food, the model reflects data that indicate
a corresponding decrease in microbiota diversity.
(B) While diet is likely a key mediator of microbiota
diversity, additional technological and medical
leaps, while providing solutions for important
problems such as infectious disease, have likely
served as insults to the microbiota. These multiple
hits have prevented the maintenance of micro-
biota diversity over recent generations.
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SCFAs to protection from diet-induced obesity (Cani et al.,
2007; Lin et al., 2012; Neyrinck et al., 2012; Zhou et al., 2009).
It remains to be determined how dietary MAC consumption influ-
ences the thousands of microbiota-produced metabolites and
the resulting influence on host biology (Marcobal et al., 2013;
Nicholson et al., 2012; Russell et al., 2011, 2013).
Effects from decreased SCFA output on the low-MAC West-
ern diet may be compounded by changes in microbiota locali-
zation and barrier disruption in the distal gut. The paucity of
fermentable carbohydrates selects for a community of microbes
that are adept at eating host-derived MACs found in the intesti-
nal mucus layer. Consumption of host mucins by many gut
species serves as a consistent endogenous source of energy
for the microbiota in the absence of dietary polysaccharides
(Sonnenburg et al., 2005). The long-term effects of low dietary
MACs on the gut mucus depletion, barrier function, and inflam-
mation have not been studied in detail; however, genetic mucus
depletion in mice results in microbiota-induced inflammation
and ultimately colitis (Johansson et al., 2014; Van der Sluis
et al., 2006).
The Future: Looking to the Past
Whether the ancient microbiota is a better microbiota is debat-
able; however, at least two arguments support this idea: (1) our
human genome lacks the plasticity that our microbiota pos-
sesses and therefore has not been able to keep pace with the
recent profound changes brought on by our modern lifestyle,
such as the consequences of a diet very low in microbiota-
accessible carbohydrates (e.g., low diversity microbiota, less
SCFA production); and (2) traditional societies typically have
much lower rates of Western diseases (Wirsing, 1985).
The plasticity of our microbiota in response to diet was likely
highly adaptive in an ancient environment. In delegating part
of our digestion and calorie harvest to our gut residents, the mi-Cell Metabolism 20,crobial part of our biology could easily
adjust to day-to-day or season-to-season
variation in available food. Considering
the remarkable resilience of the gut com-
munity to short-term perturbation, it is
likely that microbiota adaptation is largely
reversible on short time scales (David
et al., 2014; Dethlefsen and Relman,
2010; Lee et al., 2013). However, the abil-ity of the microbiota to accommodate dietary change may be
deleterious to its own maintenance and ultimately to our health
in the context of MAC deprivation that has occurred over gener-
ations in industrialized countries. In addition to the loss of micro-
bial species with which we have coevolved, the lack of MACs
required to fuel this community results in profound functional
changes, such as decreases in SCFA production.
Undoubtedly, sudden changes in human diet throughout
evolution resulting from major lifestyle changes (e.g., cooking,
hunting with weapons, and farming) were accompanied by
fundamental shifts in microbiota composition and function
(Figure 3A). These new configurations of the microbiota likely
introduced suboptimal interactions with many aspects of human
biology; however, such interactions would be expected to
optimize over millennia. It is possible that the new microbiota
configuration resulting from modern diet and lifestyle presents
incompatibilities with our human biology, the ill effects of which
contribute significantly to many modern diseases (Figure 3B)
(Blaser and Falkow, 2009).
Significant questions remain unanswered to address how
large of a role the Western microbiota plays in modern diseases.
How important is the loss of coevolved microbial species versus
the loss of microbial metabolites? Would a more sensible diet
that increases MAC content be sufficient to recover microbiota
diversity, or have species been irreversibly lost? Does imposing
a high-MAC diet on a Western microbiota present new incom-
patibilities and potential unanticipated negative health conse-
quences? We must be aware that ongoing dissemination of the
industrialized lifestyle and processed foods to the most remote
areas of the globe will be accompanied by a series of microbial
extinction events similar to that which has left the biodiversity
of the Western microbiota decimated. While imposing poorer
health on populations as they modernize, the global eradication
of critical microbiota members will likely have far-reaching
importance. These remaining untouched populations mayNovember 4, 2014 ª2014 Elsevier Inc. 783
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lost from Western populations. Collection and preservation of
these microbes followed by their deliberate reintroduction sup-
ported by a diet rich in the MACs that sustain them might be
the best hope of rewilding the Western microbiota.ACKNOWLEDGMENTS
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